Interestingly, as shown in Table 3B, LMO1 was identified as an independent predictor in both datasets in a specific patient subgroup, the stage I-II Caucasian adenocarcinoma patients without adjuvant or neoadjuvant chemotherapy. The gene discussed is LMO1; the disease is adenocarcinoma.